Global Neuropeptide Y Receptor Market Insights, Forecast to 2025
- QYR2792334
- 117 Pages
- October 2018
- Medical Devices
Increase in prevalence of various diseases related to obesity and surge in overweight populace drives the market.
Moreover, unhealthy urban lifestyle and increase in number of fast food eating populace susceptible to sudden weight gain, is expected to boost the market growth.
However, number of limited manufacturers and distribution channels is anticipated to impede the market growth.
The global Neuropeptide Y Receptor market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Neuropeptide Y Receptor market based on company, product type, end user and key regions.
This report studies the global market size of Neuropeptide Y Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neuropeptide Y Receptor in these regions.
This research report categorizes the global Neuropeptide Y Receptor market by top players/brands, region, type and end user. This report also studies the global Neuropeptide Y Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech
Market size by Product
Food Grade
Pharmaceutical Grade
Market size by End User
Medicine
Food Additives
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Neuropeptide Y Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Neuropeptide Y Receptor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neuropeptide Y Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neuropeptide Y Receptor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neuropeptide Y Receptor are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neuropeptide Y Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Neuropeptide Y Receptor Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Product
1.4.2 Food Grade
1.4.3 Pharmaceutical Grade
1.5 Market by End User
1.5.1 Global Neuropeptide Y Receptor Market Size Growth Rate by End User
1.5.2 Medicine
1.5.3 Food Additives
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neuropeptide Y Receptor Market Size
2.1.1 Global Neuropeptide Y Receptor Revenue 2013-2025
2.1.2 Global Neuropeptide Y Receptor Sales 2013-2025
2.2 Neuropeptide Y Receptor Growth Rate by Regions
2.2.1 Global Neuropeptide Y Receptor Sales by Regions
2.2.2 Global Neuropeptide Y Receptor Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Neuropeptide Y Receptor Sales by Manufacturers
3.1.1 Neuropeptide Y Receptor Sales by Manufacturers
3.1.2 Neuropeptide Y Receptor Sales Market Share by Manufacturers
3.1.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI)
3.2 Neuropeptide Y Receptor Revenue by Manufacturers
3.2.1 Neuropeptide Y Receptor Revenue by Manufacturers (2013-2018)
3.2.2 Neuropeptide Y Receptor Revenue Share by Manufacturers (2013-2018)
3.3 Neuropeptide Y Receptor Price by Manufacturers
3.4 Neuropeptide Y Receptor Manufacturing Base Distribution, Product Types
3.4.1 Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuropeptide Y Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Neuropeptide Y Receptor Sales by Product
4.2 Global Neuropeptide Y Receptor Revenue by Product
4.3 Neuropeptide Y Receptor Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Neuropeptide Y Receptor Breakdown Data by End User
6 North America
6.1 North America Neuropeptide Y Receptor by Countries
6.1.1 North America Neuropeptide Y Receptor Sales by Countries
6.1.2 North America Neuropeptide Y Receptor Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Neuropeptide Y Receptor by Product
6.3 North America Neuropeptide Y Receptor by End User
7 Europe
7.1 Europe Neuropeptide Y Receptor by Countries
7.1.1 Europe Neuropeptide Y Receptor Sales by Countries
7.1.2 Europe Neuropeptide Y Receptor Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuropeptide Y Receptor by Product
7.3 Europe Neuropeptide Y Receptor by End User
8 Asia Pacific
8.1 Asia Pacific Neuropeptide Y Receptor by Countries
8.1.1 Asia Pacific Neuropeptide Y Receptor Sales by Countries
8.1.2 Asia Pacific Neuropeptide Y Receptor Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Neuropeptide Y Receptor by Product
8.3 Asia Pacific Neuropeptide Y Receptor by End User
9 Central & South America
9.1 Central & South America Neuropeptide Y Receptor by Countries
9.1.1 Central & South America Neuropeptide Y Receptor Sales by Countries
9.1.2 Central & South America Neuropeptide Y Receptor Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Neuropeptide Y Receptor by Product
9.3 Central & South America Neuropeptide Y Receptor by End User
10 Middle East and Africa
10.1 Middle East and Africa Neuropeptide Y Receptor by Countries
10.1.1 Middle East and Africa Neuropeptide Y Receptor Sales by Countries
10.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Neuropeptide Y Receptor by Product
10.3 Middle East and Africa Neuropeptide Y Receptor by End User
11 Company Profiles
11.1 Gila Therapeutics
11.1.1 Gila Therapeutics Company Details
11.1.2 Company Business Overview
11.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
11.1.5 Gila Therapeutics Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Company Business Overview
11.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Novo Nordisk Neuropeptide Y Receptor Products Offered
11.2.5 Novo Nordisk Recent Development
11.3 XL-protein
11.3.1 XL-protein Company Details
11.3.2 Company Business Overview
11.3.XL-protein Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.3.4 XL-protein Neuropeptide Y Receptor Products Offered
11.3.5 XL-protein Recent Development
11.4 Lilly Eli
11.4.1 Lilly Eli Company Details
11.4.2 Company Business Overview
11.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Lilly Eli Neuropeptide Y Receptor Products Offered
11.4.5 Lilly Eli Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Company Business Overview
11.5.3 Novartis Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Novartis Neuropeptide Y Receptor Products Offered
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Pfizer Neuropeptide Y Receptor Products Offered
11.6.5 Pfizer Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Details
11.7.2 Company Business Overview
11.7.3 Merck & Co Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Merck & Co Neuropeptide Y Receptor Products Offered
11.7.5 Merck & Co Recent Development
11.8 Mannkind
11.8.1 Mannkind Company Details
11.8.2 Company Business Overview
11.8.3 Mannkind Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Mannkind Neuropeptide Y Receptor Products Offered
11.8.5 Mannkind Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Company Business Overview
11.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Gilead Sciences Neuropeptide Y Receptor Products Offered
11.9.5 Gilead Sciences Recent Development
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Company Business Overview
11.10.3 Genentech Neuropeptide Y Receptor Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Genentech Neuropeptide Y Receptor Products Offered
11.10.5 Genentech Recent Development
12 Future Forecast
12.1 Neuropeptide Y Receptor Market Forecast by Regions
12.1.1 Global Neuropeptide Y Receptor Sales Forecast by Regions 2018-2025
12.1.2 Global Neuropeptide Y Receptor Revenue Forecast by Regions 2018-2025
12.2 Neuropeptide Y Receptor Market Forecast by Product
12.2.1 Global Neuropeptide Y Receptor Sales Forecast by Product 2018-2025
12.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Product 2018-2025
12.3 Neuropeptide Y Receptor Market Forecast by End User
12.4 North America Neuropeptide Y Receptor Forecast
12.5 Europe Neuropeptide Y Receptor Forecast
12.6 Asia Pacific Neuropeptide Y Receptor Forecast
12.7 Central & South America Neuropeptide Y Receptor Forecast
12.8 Middle East and Africa Neuropeptide Y Receptor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neuropeptide Y Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Neuropeptide Y Receptor Product Picture
Table Neuropeptide Y Receptor Market Segments
Table Key Manufacturers Neuropeptide Y Receptor Covered
Table Global Neuropeptide Y Receptor Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Neuropeptide Y Receptor Sales Market Share by Product 2013-2025
Figure Food Grade Product Picture
Table Major Manufacturers of Food Grade
Figure Pharmaceutical Grade Product Picture
Table Major Manufacturers of Pharmaceutical Grade
Table Global Neuropeptide Y Receptor Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Medicine
Figure Food Additives
Figure Others
Figure Neuropeptide Y Receptor Report Years Considered
Figure Global Neuropeptide Y Receptor Market Size 2013-2025 (Million US$)
Figure Global Neuropeptide Y Receptor Sales 2013-2025 (K Units)
Table Global Neuropeptide Y Receptor Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Neuropeptide Y Receptor Sales by Regions 2013-2018 (K Units)
Table Global Neuropeptide Y Receptor Sales Market Share by Regions 2013-2018
Figure Global Neuropeptide Y Receptor Sales Market Share by Regions 2013-2018
Figure 2017 Global Neuropeptide Y Receptor Sales Market Share by Regions
Table Global Neuropeptide Y Receptor Revenue by Regions 2013-2018 (Million US$)
Table Global Neuropeptide Y Receptor Revenue Market Share by Regions 2013-2018
Figure Global Neuropeptide Y Receptor Revenue Market Share by Regions 2013-2018
Figure 2017 Global Neuropeptide Y Receptor Revenue Market Share by Regions
Table Global Neuropeptide Y Receptor Sales by Manufacturers (2013-2018) (K Units)
Table Global Neuropeptide Y Receptor Sales Share by Manufacturers (2013-2018)
Figure Global Neuropeptide Y Receptor Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Neuropeptide Y Receptor Revenue by Manufacturers (2013-2018) (Million USD)
Table Neuropeptide Y Receptor Revenue Share by Manufacturers (2013-2018)
Figure Neuropeptide Y Receptor Value Share by Manufacturers in 2017
Table Key Manufacturers Neuropeptide Y Receptor Price (2013-2018) (USD/Unit)
Table Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Neuropeptide Y Receptor Product Type
Table Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table Global Neuropeptide Y Receptor Sales Share by Product (2013-2018)
Figure Global Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure Global Neuropeptide Y Receptor Sales Market Share by Product in 2017
Table Global Neuropeptide Y Receptor Revenue by Product (2013-2018) (Million US$)
Table Global Neuropeptide Y Receptor Revenue Share by Product (2013-2018)
Figure Global Neuropeptide Y Receptor Revenue Market Share by Product (2013-2018)
Figure Global Neuropeptide Y Receptor Revenue Market Share by Product in 2017
Table Neuropeptide Y Receptor Price by Product 2013-2018 (USD/Unit)
Table Global Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table Global Neuropeptide Y Receptor Sales Share by End User (2013-2018)
Figure Global Sales Neuropeptide Y Receptor Market Share by End User (2013-2018)
Figure Global Sales Neuropeptide Y Receptor Market Share by End User in 2017
Figure North America Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)
Figure North America Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)
Table North America Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)
Table North America Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)
Figure 2017 North America Neuropeptide Y Receptor Sales Market Share by Countries
Table North America Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)
Table North America Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Neuropeptide Y Receptor Revenue Market Share by Countries
Figure United States Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure United States Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Canada Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Table North America Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table North America Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure 2017 North America Neuropeptide Y Receptor Market Share by Product
Table North America Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table North America Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)
Figure 2017 North America Neuropeptide Y Receptor Market Share by End User
Figure Europe Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)
Figure Europe Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)
Table Europe Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Neuropeptide Y Receptor Sales Market Share by Countries
Table Europe Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)
Table Europe Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Neuropeptide Y Receptor Revenue Market Share by Countries
Figure Germany Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Germany Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure France Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure France Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure UK Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Italy Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Russia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table Europe Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure 2017 Europe Neuropeptide Y Receptor Market Share by Product
Table Europe Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table Europe Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)
Figure 2017 Europe Neuropeptide Y Receptor Market Share by End User
Figure Asia Pacific Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Neuropeptide Y Receptor Sales Market Share by Countries
Table Asia Pacific Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Countries
Figure China Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure China Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Japan Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Korea Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure India Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure India Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Australia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Neuropeptide Y Receptor Market Share by Product
Table Asia Pacific Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table Asia Pacific Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Neuropeptide Y Receptor Market Share by End User
Figure Central & South America Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)
Table Central & South America Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Neuropeptide Y Receptor Sales Market Share by Countries
Table Central & South America Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Neuropeptide Y Receptor Revenue Market Share by Countries
Figure Brazil Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table Central & South America Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Neuropeptide Y Receptor Market Share by Product
Table Central & South America Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table Central & South America Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Neuropeptide Y Receptor Market Share by End User
Figure Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Neuropeptide Y Receptor Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Neuropeptide Y Receptor Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Countries
Table Middle East and Africa Neuropeptide Y Receptor Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Countries
Figure GCC Countries Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Neuropeptide Y Receptor Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Neuropeptide Y Receptor Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Neuropeptide Y Receptor Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Neuropeptide Y Receptor Market Share by Product
Table Middle East and Africa Neuropeptide Y Receptor Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Neuropeptide Y Receptor Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Neuropeptide Y Receptor Market Share by End User
Table Gila Therapeutics Company Details
Table Gila Therapeutics Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Gila Therapeutics Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novo Nordisk Recent Development
Table XL-protein Company Details
Table XL-protein Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table XL-protein Recent Development
Table Lilly Eli Company Details
Table Lilly Eli Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Lilly Eli Recent Development
Table Novartis Company Details
Table Novartis Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Recent Development
Table Merck & Co Company Details
Table Merck & Co Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck & Co Recent Development
Table Mannkind Company Details
Table Mannkind Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mannkind Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Gilead Sciences Recent Development
Table Genentech Company Details
Table Genentech Neuropeptide Y Receptor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Genentech Recent Development
Table Global Neuropeptide Y Receptor Sales Forecast by Regions 2018-2025 (K Units)
Table Global Neuropeptide Y Receptor Sales Market Share Forecast by Regions 2018-2025
Table Global Neuropeptide Y Receptor Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Neuropeptide Y Receptor Revenue Market Share Forecast by Regions 2018-2025
Table Global Neuropeptide Y Receptor Sales Forecast by Product 2018-2025 (K Units)
Table Global Neuropeptide Y Receptor Sales Market Share Forecast by Product 2018-2025
Table Global Neuropeptide Y Receptor Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Neuropeptide Y Receptor Revenue Market Share Forecast by Product 2018-2025
Table Global Neuropeptide Y Receptor Sales Forecast by End User 2018-2025 (K Units)
Table Global Neuropeptide Y Receptor Sales Market Share Forecast by End User 2018-2025
Figure North America Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Neuropeptide Y Receptor Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Neuropeptide Y Receptor Value Chain
Table Neuropeptide Y Receptor Customers List
Table Neuropeptide Y Receptor Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
